These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21528474)

  • 1. Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS).
    Lenarcik A; Bidzińska-Speichert B; Tworowska-Bardzińska U; Krępuła K
    Endokrynol Pol; 2011; 62(2):129-33. PubMed ID: 21528474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.
    Govind A; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1999 Jan; 84(1):38-43. PubMed ID: 9920059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
    Petermann TS; Cartes A; Maliqueo M; Vantman D; Gutiérrez C; Toloza H; Echiburú B; Recabarren SE
    Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which hormone tests for the diagnosis of polycystic ovary syndrome?
    Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
    Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.
    Liu DM; Torchen LC; Sung Y; Paparodis R; Legro RS; Grebe SK; Singh RJ; Taylor RL; Dunaif A
    Hum Reprod; 2014 Dec; 29(12):2764-72. PubMed ID: 25336708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?
    Szydlarska D; Grzesiuk W; Trybuch A; Kondracka A; Kowalik I; Bar-Andziak E
    Endokrynol Pol; 2012; 63(5):356-61. PubMed ID: 23115068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S; van der Spuy ZM
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
    Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
    Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
    Barth JH; Field HP; Yasmin E; Balen AH
    Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
    Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
    Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.
    Wachs DS; Coffler MS; Malcom PJ; Shimasaki S; Chang RJ
    J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
    Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.